Key statistics
On Thursday, Bio-Techne Corp (T1CH34:SAO) closed at 13.44, -12.84% below its 52-week high of 15.42, set on Nov 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 13.44 |
---|---|
High | 13.44 |
Low | 13.44 |
Bid | -- |
Offer | -- |
Previous close | 13.44 |
Average volume | 6.60 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Annual div (ADY) | 0.0402 BRL |
---|---|
Annual div yield (ADY) | 0.30% |
Div ex-date | Nov 08 2024 |
Div pay-date | Nov 28 2024 |
Data delayed at least 15 minutes, as of Nov 21 2024 14:58 GMT.
More ▼
Press releases
- BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
- BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
- BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO
- UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
- BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
- BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
- ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene Therapy
- BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING
- LUNAPHORE COMET™ PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH
- BIO-TECHNE DECLARES DIVIDEND
More ▼